Tianda Pharmaceuticals Ltd. (0455) Financial Statements

0 Followers

Tianda Pharmaceuticals Ltd. Financial Overview

Tianda Pharmaceuticals Ltd.'s market cap is currently HK$195.65M. The company's EPS TTM is HK$-0.0171; its P/E ratio is -3.96; Tianda Pharmaceuticals Ltd. is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Mar 21
Income Statement
Total Revenue	HK$ 322.94M	HK$ 329.94M	HK$ 532.09M	HK$ 546.69M	HK$ 509.96M
Gross Profit	HK$ 133.31M	HK$ 152.02M	HK$ 255.53M	HK$ 251.52M	HK$ 241.22M
Operating Income	HK$ -54.09M	HK$ -54.15M	HK$ -29.02M	HK$ -70.14M	HK$ -38.97M
EBITDA	HK$ -24.41M	HK$ -49.49M	HK$ 15.66M	HK$ -19.89M	HK$ -5.14M
Net Income	HK$ -70.00M	HK$ -61.37M	HK$ -24.16M	HK$ -54.64M	HK$ -21.67M
Balance Sheet
Cash & Short-Term Investments	HK$ 64.81M	HK$ 85.69M	HK$ 162.44M	HK$ 343.44M	HK$ 334.00M
Total Assets	HK$ 747.83M	HK$ 765.02M	HK$ 917.29M	HK$ 1.09B	HK$ 1.16B
Total Debt	HK$ 132.66M	HK$ 127.44M	HK$ 113.60M	HK$ 141.05M	HK$ 160.43M
Net Debt	HK$ 67.85M	HK$ 41.76M	HK$ -48.84M	HK$ -199.23M	HK$ -173.57M
Total Liabilities	HK$ 291.46M	HK$ 259.36M	HK$ 325.35M	HK$ 434.23M	HK$ 375.08M
Stockholders' Equity	HK$ 456.64M	HK$ 505.84M	HK$ 592.07M	HK$ 627.83M	HK$ 756.75M
Cash Flow
Free Cash Flow	HK$ 2.80M	HK$ -52.30M	HK$ -116.04M	HK$ 54.73M	HK$ -61.98M
Operating Cash Flow	HK$ 14.42M	HK$ -9.70M	HK$ -49.76M	HK$ 79.11M	HK$ -8.23M
Investing Cash Flow	HK$ -20.38M	HK$ -31.77M	HK$ -69.10M	HK$ -12.20M	HK$ 86.35M
Financing Cash Flow	HK$ -15.31M	HK$ -30.65M	HK$ -57.39M	HK$ -28.98M	HK$ -1.29M

Currency in HKD

Tianda Pharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

Tianda Pharmaceuticals Ltd. Debt to Assets

Balance Sheet >

Tianda Pharmaceuticals Ltd. Cash Flow

Cash Flow >

Tianda Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >